Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Large Section Of Vietnam's Populace Lacks Access to Affordable Essential Drugs - University And Health Ministry Researchers

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - While price levels on drugs in Vietnam are relatively high when compared with average incomes nationwide, the government has been moving to control prices, in part to improve access to essential medicines

You may also be interested in...



GSK And Singapore's Economic Development Board Finance Asian Public Health Research Through Public-Private Fund

SINGAPORE - The National University of Singapore has set up an initiative to advance public health and healthcare delivery in Asia. The 10-year initiative will be funded with S$17 million ($12.3 million) from the GSK-EDB Trust Fund, a joint fund created by GlaxoSmithKline and Singapore's Economic Development Board

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC075431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel